Trademarks = 2

Forward Citations = 859

Loading Chart...

1 inventor (with patents filed for the assignee):

Peter Van Vlasselaer (6 out of 9 patents)

6 patents: Sort by Forward Citations

1. 5840502 - Methods for enriching specific cell-types by density gradient (1998-11-24),

2. 5663051 - Separation apparatus and method (1997-09-02),

3. 5648223 - Methods for enriching breast tumor cells (1997-07-15),

4. 5646004 - Methods for enriching fetal cells from maternal body fluids (1997-07-08),

5. 5577513 - Centrifugation syringe, system and method (1996-11-26),

6. 5474687 - Methods for enriching CD34.sup.+ human hematopoietic progenitor cells (1995-12-12),

Company Overview

Activated Cell Therapy, Inc. is a biotechnology company focused on developing innovative cell-based therapies for various diseases. Our team of experts specialize in harnessing the power of the immune system to create personalized treatment options for patients. With cutting-edge technology and a commitment to research and development, we strive to make a meaningful impact in the field of cell therapy.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#358 in Mountain View, CA

#10,578 in California

#45,007 in US

Mountain View, CA, United States of America

Activated Cell Therapy, Inc.

Forward Citations = 859

1 inventor:

Peter Van Vlasselaer (6 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Activated Cell Therapy, Inc.. Retrieved from https://idiyas.com/company/activated-cell-therapy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]